PSA

Survey: Leading Urologists Favor Routine PSA Tests

October 31, 2011

Most leading urologists recommend routine PSA testing for men aged 50 and older, despite a recent U.S. panel's recommendation, according to a survey by U.S. News World & Report.
 

MRI Scans May Improve PCa Recurrence at Low PSA Levels

May 03, 2011

Dynamic contrast enhanced (DCE) endorectal magnetic resonance imaging (MRI) of the pelvis may offer an effective method of assessing for local recurrence of prostate cancer (PCa) after prostatectomy, according to Texas researchers.
 

High PSA Velocity Alone Is Not Enough Reason for Biopsy

March 29, 2011

An analysis of 5,519 men undergoing biopsy in the control arm of the Prostate Cancer Prevention Trial uncovered no evidence to support the recommendation that men with high PSA velocity be biopsied in the absence of other indications, according to an online report in the Journal of the National Cancer Institute.
 

PSA at Age 60 Predicts Prostate Cancer Death Risk

October 01, 2010

PSA levels measured at age 60 predict a man's lifetime risk of metastasis and death from prostate cancer (PCa), according to a study published online in the British Medical Journal.
 

Baseline PSA Predicts Prostate Cancer Death Risk

September 24, 2010

Baseline PSA levels reliably and independently predicts death from prostate cancer, with a baseline reading of 4 ng/mL or higher linked with greater mortality risk.
 

Initial PSA Value After Salvage Cryoablation Predictive

September 24, 2010

Initial PSA levels following salvage cryoabation in prostate cancer patients who failed radiation therapy may predict the likelihood of long-term biochemical progression, researchers found.
 

PSA Testing Found to Reduce Prostate Cancer Mortality

August 19, 2010

Deaths from prostate cancer (PCa) fell by almost half after 14 years of biennial screening, according to data from a Swedish study.
 

PSA Rises More Slowly with Age in Diabetics

June 03, 2010

SAN FRANCISCO—Men with diabetes experience significantly smaller increases in PSA level as they age compared with non-diabetics, according to findings reported here at the American Urological Association Annual Meeting.
 

PSA Lower in Aspirin-Using Never Smokers

April 01, 2010

Aspirin use is associated with lower PSA levels in men who have never smoked, data suggest.
 

PCA3 Beats PSA in Predicting Prostate Biopsy Outcomes

March 05, 2010

SAN FRANCISCO—The prostate cancer gene 3 (PCA3) molecular urine test is more accurate than the PSA test in predicting outcomes of repeat biopsies, new findings confirm.
 

PSA Levels Decline After The Start of Statin Therapy

January 15, 2010

Onset of statin use is associated with a significant reduction in serum PSA level, data suggest.
 

PSA Testing Rate Highest in Blacks

December 15, 2009

A study of a large multiethnic cohort found that African-American men had a higher prevalence of PSA screening than white and Latino men.
 

Undetectable PSA Possible With Radiation

December 10, 2009

After a median of 32 months, PSA was undetectable in 12% of patients.
 

BMI Affects PSA Test Results in Whites

September 18, 2009

The likelihood of an abnormal finding is 46% lower in obese men than normal-weight men, study shows
 

PSM Site Predicts PSA Relapse Risk

September 17, 2009

Positive margins at the prostate base are associated with the worst outcomes.
 

Adenovirus/PSA Vaccine Shows Promise

September 17, 2009

Researchers observe positive T cell responses in men with nonmetastatic recurrence prostate cancer.
 

PSADT Predicts Mortality

July 22, 2009

Among men who experience PSA recurrence following radical prostatectomy (RP) for prostate cancer, a PSA doubling time (PSADT) of less than nine months at the time of recurrence is associated with a significantly increased risk of death, according to a study.
 

PSAs of 1.5-4 Hike PCa Risk

July 13, 2009

ORLANDO—Men with PSA values of 1.5-4 ng/mL have a significantly elevated four-year risk of being diagnosed with prostate cancer compared with men who have PSA levels below 1.5, according to a retrospective study of 21,502 men.
 

Statins May Prevent PSA Relapse

June 30, 2009

Prostate cancer patients who use statins may be at lower risk of PSA recurrence after radical prostatectomy (RP) compared with those who do not use the medications, according to investigators.
 

Study Defines PCa Metastasis Predictors

June 18, 2009

PSA doubling time (PSADT), Gleason score, and time to PSA progression are strong independent predictors of metastasis-free survival in prostate cancer patients who experience PSA recurrence following radical prostatectomy (RP).
 

Soy Well-Tolerated in PCa Patients

June 18, 2009

DENVER—Consuming 20 g of soy daily for up to two years is safe and may be beneficial for men at high risk for biochemical failure after radical prostatectomy, according to preliminary findings from an ongoing study.
 

Delayed PSA Recurrence a Good Sign

June 16, 2009

PSA recurrence (PSAR) more than five years after radical prostatectomy for prostate cancer is associated with better cancer-specific survival than PSAR less than five years after surgery, a study found.
 

Pomegranate Juice May Help Prostate Cancer Patients

May 28, 2009

Pomegranate juice may help slow progression of prostate cancer in men who experience rising PSA levels following radical prostatectomy or radiotherapy, data suggest.
 

PSA Screening Cuts Prostate Cancer Death Risk

May 01, 2009

PSA screening for prostate cancer is associated with a 20% reduction in mortality from the disease, according to findings from the largest prostate cancer study ever conducted.
 

PSA Density Predicts Worse Prostate Cancer Pathology

April 29, 2009

PSA density (PSAD) predicts pathologic upstaging following radical prostatectomy (RP) for prostate cancer, a study found.
 

New AUA Recommendation: Start Offering PSA Testing at 40

April 27, 2009

CHICAGO—The American Urological Association (AUA) recommends that PSA testing should be offered to well-informed men aged 40 years and older who have a life expectancy of at least 10 years.
 

PSA Is Not Enough to Assess Prostate Cancer Risk

April 17, 2009

Canadian researchers say it may be time to move beyond PSA-based predictions of prostate cancer risk. New technology and gene-based markers make it possible to use a more individualized approach that considers all prostate cancer risk factors.
 

Prostate Cancer Possible Even if PSA Declines

March 23, 2009

Men whose PSA levels rise above 4 ng/mL—a commonly used threshold for prostate biopsy—but then decline to below this level can still harbor prostate cancer, and many of these cancers may be aggressive.
 

Prebiopsy Antibiotics May Be Unjustified

March 16, 2009

New findings raise questions about the practice of prescribing antibiotics to men prior to prostate biopsy if they have newly elevated PSA levels and a normal digital rectal examination (DRE).
 

After the PSA Cutoff Era: The Importance of Context

March 01, 2009

About two years ago, having recognized that the prostate-specific antigen (PSA) cutoff level of 4.0 ng/mL did not always assist in accurately categorizing a man's risk for prostate cancer, we began to eliminate this—or any—artificial cutoff defining a "normal" PSA value.
 
Popular Topics
Acute Kidney Injury Anemia Bladder Cancer BPH Cardiovascular Disease Chronic Kidney Disease CKD Diabetes Epidemiology Erectile Dysfunction Hemodialysis Hyperphosphatemia Hypertension Infection Kidney Cancer Kidney Stones Nutrition Overactive Bladder Peritoneal Dialysis Prostate Cancer PSA Reproductive Medicine Transplantation Urinary Incontinence UTI

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization.

Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions